AstraZeneca updated its data late Wednesday on the effectiveness of its coronavirus vaccine candidate amid U.S. concern about misleading data, but maintained that the vaccine provides strong protection against the potentially deadly virus.
Black News, Commentary and Culture | The Washington Informer
AstraZeneca updated its data late Wednesday on the effectiveness of its coronavirus vaccine candidate amid U.S. concern about misleading data, but maintained that the vaccine provides strong protection against the potentially deadly virus.
